DeğerQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSatış/genel/idari giderler1.98 B2.2 B2.07 B2.03 B1.8 B8.1 BAraştırma ve geliştirme——————Faaliyet karı1.59 B1.04 B1.41 B1.62 B2.15 B6.21 BFaaliyet Dışı Gelir, Toplam-31 M64 M62 M74 M36 M236 MFaiz gideri (aktifleştirilmiş faizler düşüldükten sonra)45 M49 M74 M63 M61 M247 MFaaliyet Dışı Gelir (Faiz Giderleri Hariç)240 M15 M-12 M11 M246 M260 MOlağandışı gelirler/giderler-271 M———-271 M—Vergi öncesi kar1.51 B1.05 B1.4 B1.63 B2.13 B6.2 BKazançlardaki özsermayeler52 M———52 M—Vergiler209 M220 M232 M380 M270 M1.1 BKontrol gücü olmayan/azınlık payı46 M47 M53 M64 M173 M337 MVergi sonrası diğer gelirler/giderler-213 M-57 M-112 M-40 M-93 M-302 MDurdurulan faaliyetler öncesi net kar1.26 B784 M1.11 B1.19 B1.68 B4.76 BDurdurulan faaliyetler0—————Net kar1.26 B784 M1.11 B1.19 B1.68 B4.76 BSeyreltme ayarlaması——————İmtiyazlı temettüler——————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar1.26 B784 M1.11 B1.19 B1.68 B4.76 BTemel hisse başına kazanç (Temel EPS)9.966.288.959.6313.6938.55Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)9.96.258.929.5913.6238.38Dolaşımdaki ortalama adi hisse senedi sayısı127.4 M124.9 M124 M123.2 M123.6 M—Dolaşımdaki seyreltilmiş hisse senedi sayısı128.1 M125.5 M124.4 M123.7 M124.1 M—FAVÖK1.74 B1.19 B1.59 B1.81 B2.35 B6.94 BFVÖK1.59 B1.04 B1.41 B1.62 B2.15 B6.21 BGelir maliyeti87.18 B94.55 B99.61 B102.47 B92.25 B388.88 BSatılan malların diğer maliyeti——————Amortisman ve itfa (nakit akışı)151 M157 M188 M188 M196 M729 M
McKesson Corporation Common Stock
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States.
Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses.